Labetalol Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

32 Suppliers, 19 USDMF, 6 CEP/COS, 4 JDMF, 4 EU WC, 15 NDC API, 16 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

10 Suppliers

10 Suppliers

DOSSIERs // Finished Dosage Forms

123 Dossiers, 76 FDA Orange Book, 12 Europe, 10 Canada, 1 Australia, 2 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG, TABLET;ORAL - 200MG, TABLET;ORAL - 300MG, TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 38 Kerry, 17 Roquette, 17 BASF, 13 Seppic, 12 Microlex e.U, 12 Gangwal Chemicals, 11 Sigachi Industries, 10 Corel Pharma Chem, 8 Gangwal Healthcare, 7 Ideal Cures Pvt Ltd, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 DFE Pharma, 6 Lonza Capsugel, 5 Nanjing Well Pharmaceutical, 5 Actylis, 4 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Pharmatrans-Sanaq, 2 The Dow Chemical Company, 2 Seqens, 2 Nomisma Healthcare, 1 Aeon Procare, 1 DKSH, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Alcedo Pharmachem, 1 Finar, 1 Ulanqab Kema New Material, 1 Jai Radhe Sales, 1 Clariant, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 33 Direct Compression, 32 Disintegrants & Superdisintegrants, 28 Controlled & Modified Release, 22 Thickeners and Stabilizers, 20 Granulation, 18 Solubilizers, 15 Lubricants & Glidants, 13 Topical, 13 Co-Processed Excipients, 12 Parenteral, 11 Film Formers & Plasticizers, 9 Chewable & Orodispersible Aids, 7 Taste Masking, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

23 APIs, 11 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 1 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

16 News

16 News

List of suppliers providing reference standards related to Labetalol Hydrochloride

Labetalol Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

32 Suppliers

19 USDMF

6 CEP/COS

4 JDMF

4 EU WC

15 NDC API

16 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

10 Suppliers

DOSSIERs // Finished Dosage Forms

123 Dossiers

76 FDA Orange Book

12 Europe

10 Canada

1 Australia

2 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG

TABLET;ORAL - 200MG

TABLET;ORAL - 300MG

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

38 Kerry

17 Roquette

17 BASF

13 Seppic

12 Microlex e.U

12 Gangwal Chemicals

11 Sigachi Industries

10 Corel Pharma Chem

8 Gangwal Healthcare

7 Ideal Cures Pvt Ltd

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 DFE Pharma

6 Lonza Capsugel

5 Nanjing Well Pharmaceutical

5 Actylis

4 SPI Pharma

4 Boai NKY Pharmaceuticals Ltd

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Prachin Chemical

3 Vasa Pharmachem

3 Ingredion Pharma Solutions

3 Kima Chemical

3 Pharmatrans-Sanaq

2 The Dow Chemical Company

2 Seqens

2 Nomisma Healthcare

1 Aeon Procare

1 DKSH

1 Qianhao Chemical (Hebei) Co., Ltd

1 Alcedo Pharmachem

1 Finar

1 Ulanqab Kema New Material

1 Jai Radhe Sales

1 Clariant

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders

48 Coating Systems & Additives

33 Direct Compression

32 Disintegrants & Superdisintegrants

28 Controlled & Modified Release

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons